BIOGEN INC. (BIIB) Options Risk Score

Run a full BIIB options risk analysis

See the complete risk breakdown — news catalysts, SEC filings, legal proceedings, earnings overlap, IV vs HV, options flow and Expected Move — all in one scan.

Is it risky to sell options on BIOGEN INC. (BIIB) right now?

For a 4-week expiry, BIOGEN INC. (BIIB) carries an options catalyst-risk score of 100 out of 100 (HIGH). That score is driven by 6 recent news items, 1 active legal filing and 14 clinical-trial catalysts falling inside the 4-week window. On TickerRisk's scale 70 and above is HIGH, so a known event is scheduled inside this window — selling premium on BIIB here is a bet on that event rather than on time decay. The score measures scheduled event exposure, not which way the stock will move.

BIIB shows an IV Rank of 100 — implied volatility is near the top of its own one-year range, so BIIB options are historically expensive, which favours premium-selling strategies, with a current implied volatility of about 259%. IV Rank is the most useful figure for deciding whether to sell or buy premium on BIIB.

BIIB's next earnings date is 2026-10-28, outside the near-term options window.

BIOGEN INC. (BIIB) current implied volatility and IV Rank

BIOGEN INC. (BIIB) currently has an IV Rank of 100 with implied volatility around 259%, alongside a TickerRisk options-risk score of 100/100. That's high — options are expensive relative to the past year, which favours premium-selling strategies such as credit spreads, iron condors and covered calls, provided no binary catalyst is working against you.

For what this number does and does not tell you about BIIB's options, see IV Rank explained.

BIOGEN INC. (BIIB) next earnings date — 2026-10-28

BIOGEN INC. (BIIB) next reports earnings on 2026-10-28 — about 7 days away. That's outside the nearest options expiry window, so it isn't an immediate catalyst — but it's worth tracking, since implied volatility typically starts building one to two weeks ahead of the report. BIIB's IV Rank is currently 100.

TickerRisk provides risk scoring for informational purposes only. This is not financial advice. Options trading involves substantial risk of loss. Full disclaimer